View Older Stories

Apr 4, 2022 11:46AM Needham & Company Reiterates Buy Rating, $205 Price Target on Alnylam Pharmaceuticals (ALNY) Despite Delay of vutrisiran, "Still Have High Confidence vutrisiran Will be Approved"

Nov 22, 2021 06:41AM Alnylam Pharmaceuticals (ALNY) PT Raised to $205 at Needham & Company Following R&D Day

Apr 6, 2021 08:00AM Alnylam to Webcast Presentation at 20th Annual Needham Virtual Healthcare Conference

Apr 13, 2020 04:00PM Alnylam to Webcast Presentation at 19th Annual Needham Virtual Healthcare Conference

Nov 13, 2019 07:15AM Companies with NDRs 11/13

Sep 27, 2019 07:15AM Companies with NDRs 09/27

Nov 7, 2018 01:35PM Alnylam Pharmaceuticals (ALNY) PT Lowered to $135 at Needham & Company

Mar 21, 2018 08:00AM Alnylam to Webcast Presentation at 17th Annual Needham Healthcare Conference

Dec 15, 2017 09:28AM Pre-Open Movers 12/15: (DDR) (ALNY) (HES) Higher; (TROV) (VSTM) (CSX) Lower (more...)

Nov 16, 2017 04:00PM Alnylam Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Nov 14, 2017 05:48AM Alnylam Pharma (ALNY) Prices 5.6M Share Common Offering at $125/Sh

Nov 13, 2017 08:02PM Alnylam Pharmaceuticals Prices Public Offering of Common Stock

Sep 20, 2017 03:20PM Alnylam Pharmaceuticals (ALNY) PT Raised to $125 at Needham & Company

Sep 7, 2017 02:05PM Needham & Company Lowrs PT on Alnylam Pharmaceuticals (ALNY) to $85

Jun 26, 2017 12:40PM Alnylam Pharmaceuticals (ALNY) PT Raised to $98 at Needham & Company

Mar 28, 2017 04:00PM Alnylam to Webcast Presentation at 16th Annual Needham Healthcare Conference

Feb 9, 2017 07:23AM Alnylam Pharma (ALNY): Cutting PT After Corporate Update - Needham

Dec 19, 2016 06:24AM Alnylam Pharma (ALNY): Reiterating Buy After R&D Day - Needham

Dec 5, 2016 07:43AM Alnylam Pharma (ALNY): ASH Presentation Bodes Well For 2017 PhIII - Needham

Nov 16, 2016 06:48AM Alnylam Pharma (ALNY): Cutting PT On Sanofi Revenue Share But Reiterating Buy - Needham

Nov 15, 2016 12:20PM Streetinsider.com's Hot Lunchtime Reads 11/15: (MDCO) (MBLY) (GOGO) (SSYS)

Oct 6, 2016 07:26AM Alnylam (ALNY) PT Cut to $137 at Needham & Company; Long-Term Investors Should Buy Weakness

Jul 1, 2016 12:58PM Needham & Company Keeps Alnylam Pharma (ALNY) at 'Buy' Following Latest Patisiran and Revusiran Data

Apr 6, 2016 04:00PM Alnylam to Webcast Presentation at 15th Annual Needham Healthcare Conference

Sep 15, 2015 12:32PM Streetinsider.com's Hot Lunchtime Reads 9/15: (TGT) (ALNY) (RAI) (FB) (GWPH)

Sep 15, 2015 11:26AM Needham & Company Reiterates Buy on Alnylam Pharma (ALNY) Following Announced Results from Part A Phase 1 of ALN-AS1

Aug 31, 2015 08:05AM Needham & Company Reiterates Buy on Alnylam Pharma (ALNY) Following Positive Phase 1 Trial Results

Apr 21, 2015 12:19PM Streetinsider.com's Hot Lunchtime Reads 4/21: (GS) (TEVA) (INO) (TWTR)

Apr 21, 2015 11:42AM Alnylam Pharmaceuticals (ALNY) Price Target Lifted to $152 at Needham & Company Amid 12-Month Data

Apr 8, 2015 04:00PM Alnylam to Webcast Presentation at 14th Annual Needham Healthcare Conference

Jan 21, 2015 06:23AM Alnylam Pharma (ALNY) Prices 4.74M Common Offering at $95/Share

Oct 13, 2014 10:15AM Needham & Company Maintains Bullish Stance on Alnylam Pharmaceuticals (ALNY) as Data Suggest Patisiran Clinical Benefit in FAP Patients

May 9, 2014 08:30AM Alnylam Pharmaceuticals (ANLY) Bullish Stance Reiterated at Needham & Company Post Q1

Feb 14, 2014 07:29AM Alnylam Pharmaceuticals (ALNY) Target Lifted to $94 at Needham & Company

Nov 14, 2013 12:15PM Streetinsider.com's Hot Lunchtime Reads 11/14: (CSCO) (YUME) (YRCW) (ALNY)

Sep 23, 2013 02:42PM Alnylam (ALNY) PT Lifted to $65 at Needham & Company on Positive ALN-TTRsc Results

Aug 9, 2013 08:39AM Needham & Company Lifts PT on Alnylam Pharmaceuticals (ALNY) to $55

Jul 11, 2013 09:30AM Streetinsider.com Pre-Open Movers 07/11: (RMTI) (BPI) (ALNY) Higher; (LEDS) (MACK) (PSMT) Lower (more...)

Feb 4, 2013 03:02PM Needham & Company Boosts Alnylam (ALNY) PT to $28 on Medicines Co. Deal

Jan 16, 2013 05:00PM Underwriters Exercise Full Overallotment in Alnylam (ALNY) Offering

Oct 4, 2012 04:09PM Regulus Therapeutics (RGLS) IPO Closes 5% Higher

Aug 7, 2012 09:02AM Needham & Company Reiterates Buy on Alnylam Pharmaceuticals (ALNY), Says Stock Undervalued

Jul 16, 2012 02:28PM Alnylam Pharmaceuticals (ALNY) Price Target Boosted at Needham & Company

May 30, 2012 01:09PM Needham & Company Reiterates a 'Buy' on Alnylam Pharma (ALNY); Phase 2b Trial Misses, But Shares Still Undervalued

May 4, 2012 09:11AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Focused on Development

Feb 15, 2012 06:40AM Alnylam (ALNY) Prices 7.5M Common Offering at $10.75/Share

Feb 10, 2012 09:35AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Accelerated ALN-TTR Development May Sustain Stock Momentum in 2012

Jan 4, 2012 12:46PM Streetinsider.com's Hot Lunchtime Reads 01/04: (MCD) (AAPL) (ALNY) (UPS) (CRM)

Jan 4, 2012 11:57AM Needham & Company Reiterates a 'Buy' on Alnylam (ALNY); Positive Results for ALN-PCS; Stock Remains a 2012 Favorite

Dec 23, 2011 07:35AM Needham & Company 2012 Biotech Preview

View Older Stories